申请人:Glaxo Group Limited
公开号:US04822881A1
公开(公告)日:1989-04-18
The invention relates to compounds of the general formula (I): ##STR1## wherein Im represents an imidazolyl group of the formula: ##STR2## and the various substituents are defined hereinbelow. The compounds are potent and selective antagonists of the effect of 5-HT at 5-HT.sub.3 receptors and are useful, for example, in the treatment of psychotic disorders, anxiety, and nausea and vomiting.
这项发明涉及一般式(I)的化合物:##STR1## 其中Im代表一种具有以下式的咪唑基团:##STR2## 各种取代基在此定义。这些化合物是5-HT.sub.3受体上5-HT效应的有效和选择性拮抗剂,例如,在治疗精神障碍、焦虑、恶心和呕吐方面是有用的。